You are currently viewing After Sputnik, US company Modern will launch single dose vaccine in India

After Sputnik, US company Modern will launch single dose vaccine in India

  • Post author:
  • Post category:Health
Own report: The United States followed in Russia’s footsteps by fighting the vaccine. After Sputnik, the US pharmaceutical company Modernna is going to launch single dose vaccine in India. The company is already in talks with Indian pharmaceutical company Cipla.

Pfizer, on the other hand, has not agreed to send the vaccine to India under India’s safety laws to capture the Indian vaccine market. A conclusion will be reached soon. After that, the government is optimistic about Pfizer’s vaccine in the country.

Read more, World Schizophrenia Day has just passed! Overcoming mental fatigue is the most important thing

Modern has recently released the results of the second and third rounds of vaccine tests on children. The vaccine has been shown to be 93% effective in children taking doses. Although the number of coronaviruses in India is currently declining, the death toll has risen sharply. The health infrastructure has also collapsed In this climate, the country is relying on vaccination.

However, there is a shortage of vaccines in the country. In this situation, the center is more optimistic about the American company Pfizer and the modern vaccine. Up has already been asked to contact Pfizer. It is learned that the discussion has progressed a lot.

Vaccines are in short supply in India due to increased demand and low production of domestic vaccines Kovacin and Kovishield. The daily vaccination rate has come down to 960 per million, from 1,455 per million a week ago, a drop of more than 35 per cent. However, as a result of lockdown and early vaccination, the number of infections has decreased.